Trump’s science shake-up and FBI probes: who’s being targeted as UFO files and “missing scientists” collide?

On April 28, 2026, multiple outlets reported sweeping personnel moves by the Trump administration affecting U.S. science governance. NRC and The Japan Times both describe the firing of the entire advisory leadership tied to the National Science Foundation’s National Science Board, an entity created in 1950 to advise the president and Congress on science and engineering policy. Separately, NZZ reports that Trump has announced plans to release UFO-related files, while a parallel thread of “missing scientists” claims has drawn FBI attention. The cluster suggests a convergence of high-salience science policy disruption and an intensifying U.S. security posture around sensitive research and information. Geopolitically, the story matters because science funding oversight and research integrity are strategic levers in great-power competition. Removing an entire board that historically positioned itself as apolitical can quickly reshape how research priorities are set, how grants are reviewed, and how international collaborations are managed. At the same time, the FBI-linked case described by Times of India alleges the arrest of a Chinese state-sponsored hacker after an Italy extradition, tied to targeted COVID-19 research and state-backed cyber espionage. If these threads are connected in the public narrative, they point to a broader U.S. attempt to tighten control over sensitive biomedical and dual-use knowledge while also managing politically charged disclosure topics like UFO records. Market and economic implications are likely to concentrate in research-intensive sectors and risk premia for technology and healthcare R&D. Changes to NSF governance can affect the pipeline of federal grants that support universities, labs, and early-stage biotech and deep-tech startups, with knock-on effects for semiconductor-adjacent instrumentation, clinical research tooling, and cybersecurity services. The alleged state-sponsored intrusion into COVID-19 research raises the probability of additional compliance and security spending across life sciences, potentially lifting demand for threat detection, secure data rooms, and incident response. While the articles do not provide direct price figures, the direction is toward higher perceived policy and security risk for U.S. science funding recipients and for firms exposed to federal research ecosystems. What to watch next is whether leadership turnover at NSF is followed by changes to grant review procedures, conflict-of-interest rules, and international collaboration guidelines. For the security angle, monitor FBI disclosures, court filings, and any follow-on indictments that clarify the scope of the alleged China-linked intrusion and the specific institutions targeted. On the UFO front, track the timing, classification decisions, and release cadence of the promised files, because disclosure policy can become a domestic political and intelligence-management stress test. Trigger points include any confirmation of “missing scientists” beyond rumor, any evidence of interference with federally funded research, and any new sanctions or export-control signals tied to cyber-enabled espionage.

Geopolitical Implications

• 01

  Science governance is becoming a strategic battleground in great-power competition.

• 02

  Cyber-enabled interference in biomedical research is driving tighter U.S. security and compliance posture.

• 03

  UFO disclosure policy may intersect with intelligence-management constraints and domestic political friction.

Key Signals

• —New NSF/NSB leadership and any changes to grant review or collaboration rules.
• —Court and FBI disclosures detailing the alleged China-linked intrusion and targeted institutions.
• —Verification or debunking of “missing scientists” claims with concrete investigative outcomes.
• —UFO file release schedule, redaction decisions, and any intelligence-agency pushback.